Evidence map›Paper›PMID 29782530›Full record

ArticlePLoS pathogens2018

Histone methylation changes are required for life cycle progression in the human parasite Schistosoma mansoni.

David Roquis, Aaron Taudt, Kathrin K Geyer, Gilda Padalino, Karl F Hoffmann, Nancy Holroyd, Matt Berriman, Benoît Aliaga, Cristian Chaparro, Christoph Grunau and 1 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. DNA methylation in invertebrate genomes and cell lineage plasticity.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Small Molecule Ligands of the BET-like Bromodomain,Journal of medicinal chemistry · 2023
    Article
  10. Functional genomics in Spiralia.Briefings in functional genomics · 2023
    Article
  11. Frontiers in microbiology · 2023
    Article
  12. Chemical modulation ofWellcome open research · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David RoquisTechnical University of Munich, Department of Plant Sciences, Freising, Germany.
Aaron TaudtEuropean Institute for the Biology of Aging, University of Groningen, University Medical Centre Groningen, AV Groningen, The Netherlands.ORCID 0000-0002-9639-2306
Kathrin K GeyerInstitute of Biological, Environmental, and Rural Sciences (IBERS), Aberystwyth University, Penglais, Aberystwyth, Ceredigion, United Kingdom.
Gilda PadalinoInstitute of Biological, Environmental, and Rural Sciences (IBERS), Aberystwyth University, Penglais, Aberystwyth, Ceredigion, United Kingdom.
Karl F HoffmannInstitute of Biological, Environmental, and Rural Sciences (IBERS), Aberystwyth University, Penglais, Aberystwyth, Ceredigion, United Kingdom.ORCID 0000-0002-3932-5502
Nancy HolroydWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.ORCID 0000-0003-2608-7151
Matt BerrimanWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.ORCID 0000-0002-9581-0377
Benoît AliagaUniv. Perpignan Via Domitia, IHPE UMR 5244, CNRS, IFREMER, Univ. Montpellier, Perpignan, France.ORCID 0000-0002-9724-7004
Cristian ChaparroUniv. Perpignan Via Domitia, IHPE UMR 5244, CNRS, IFREMER, Univ. Montpellier, Perpignan, France.ORCID 0000-0002-5162-349X
Christoph GrunauUniv. Perpignan Via Domitia, IHPE UMR 5244, CNRS, IFREMER, Univ. Montpellier, Perpignan, France.ORCID 0000-0002-2161-412X
Ronaldo de Carvalho AugustoUniv. Perpignan Via Domitia, IHPE UMR 5244, CNRS, IFREMER, Univ. Montpellier, Perpignan, France.ORCID 0000-0003-1147-0043

Funding

Wellcome Trust
6 · The paper itself

Abstract

Epigenetic mechanisms and chromatin structure play an important role in development. Their impact is therefore expected to be strong in parasites with complex life cycles and multiple, strikingly different, developmental stages, i.e. developmental plasticity. Some studies have already described how the chromatin structure, through histone modifications, varies from a developmental stage to another in a few unicellular parasites. While H3K4me3 profiles remain relatively constant, H3K27 trimethylation and bivalent methylation show strong variation. Inhibitors (A366 and GSK343) of H3K27 histone methyltransferase activity in S. mansoni efficiently blocked miracidium to sporocyst transition indicating that H3K27 trimethylation is required for life cycle progression. As S. mansoni is a multicellular parasite that significantly affects both the health and economy of endemic areas, a better understanding of fluke developmental processes within the definitive host will likely highlight novel disease control strategies. Towards this goal, we also studied H4K20me1 in female cercariae and adults. In particular, we found that bivalent trimethylation of H3K4 and H3K27 at the transcription start site of genes is a landmark of the cercarial stage. In cercariae, H3K27me3 presence and strong enrichment in H4K20me1 over long regions (10-100 kb) is associated with development related genes. Here, we provide a broad overview of the chromatin structure of a metazoan parasite throughout its most important lifecycle stages. The five developmental stages studied here present distinct chromatin structures, indicating that histone methylation plays an important role during development. Hence, components of the histone methylation (and demethylation) machinery may provide suitable Schistosomiasis control targets.

Indexed as

AnimalsBiomphalariaChromatinChromatin ImmunoprecipitationCricetinaeFemaleFresh WaterHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHistonesHumansLife Cycle StagesLiverMaleMethylationMiceChromatinHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHistones

Identifiers

PMID29782530
PMCPMC5983875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.